2024
Stalled Scale-Up of Opioid Agonist Therapies for HIV Prevention in Kazakhstan: History, Policy, and Recommendations for Change
Liberman A, Ivasiy R, Altice F, Bromberg D, Ibragimova O, Seksenova Z, Madden L, Primbetova S, Terlikbayeva A. Stalled Scale-Up of Opioid Agonist Therapies for HIV Prevention in Kazakhstan: History, Policy, and Recommendations for Change. Journal Of Illicit Economies And Development 2024, 5: 69-77. DOI: 10.31389/jied.208.Peer-Reviewed Original Research
2023
Aligning public health and public safety: Probation as a touchpoint to identify and link patients with opioid use disorder to opioid agonist treatment
Bromberg D, Galvez de Leon S, Litz T, Azbel L, Liberman A, Polonsky M, Dvoriak S, Saichuk N, Taxman F, Altice F. Aligning public health and public safety: Probation as a touchpoint to identify and link patients with opioid use disorder to opioid agonist treatment. PLOS Global Public Health 2023, 3: e0002349. PMID: 37910486, PMCID: PMC10619786, DOI: 10.1371/journal.pgph.0002349.Peer-Reviewed Original ResearchCriminal justice settingsOpioid use disorderBrief interventionUse disordersPrevalence of OUDProbation centersHIV prevention effortsJustice settingsMental healthHigh rateCommunity supervision settingsOAT servicesSBIRT interventionAgonist therapyHIV testingOpioid dependenceAgonist treatmentConsecutive individualsTreatment strategiesGeneral populationProbationSBIRTPrevention effortsSupervision settingParticipantsThe Properties and Domain Requirements for Phase Separation of the Sup35 Prion Protein In Vivo
Grimes B, Jacob W, Liberman A, Kim N, Zhao X, Masison D, Greene L. The Properties and Domain Requirements for Phase Separation of the Sup35 Prion Protein In Vivo. Biomolecules 2023, 13: 1370. PMID: 37759770, PMCID: PMC10526957, DOI: 10.3390/biom13091370.Peer-Reviewed Original Research
2022
Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons
Liberman AR, Bromberg DJ, Litz T, Kurmanalieva A, Galvez S, Rozanova J, Azbel L, Meyer JP, Altice FL. Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons. PLOS ONE 2022, 17: e0276723. PMID: 36282864, PMCID: PMC9595522, DOI: 10.1371/journal.pone.0276723.Peer-Reviewed Original ResearchConceptsKyrgyz prisonsCriminal justice systemDepth qualitative interviewsMethadone utilizationMethadone treatmentMixed-method analysisBrief interventionJustice systemPrison systemCriminal subcultureQualitative interviewsEastern EuropeEvidence-based HIV prevention strategiesCentral AsiaKyrgyz RepublicQualitative findingsPrison releaseHIV prevention strategiesPrisonInjection drug useMedication-assisted therapyMethadone uptakeInterpersonal relationshipsAttitudesHealth-related concerns
2021
Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study
O'Hara GL, Liberman AR, Polonsky M, Azbel L, Marcus R, Doltu S, Cugut S, Altice FL. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study. Journal Of Substance Use And Addiction Treatment 2021, 136: 108660. PMID: 34801282, PMCID: PMC10879837, DOI: 10.1016/j.jsat.2021.108660.Peer-Reviewed Original ResearchConceptsMethadone maintenance treatmentCentral Asian regionNegative personal attitudesPrison hierarchySocial forcesInformal hierarchyMaintenance treatmentThematic barriersQualitative interviewsPrison populationInterview dataAsian regionPrisonPrison settingQualitative studyQuantitative surveyKey barriersNew HIV infectionsOpioid use disorderContent analysisComplete interview dataQualitative analysisDistrustPersonal attitudesPrisonersDecisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information
Liberman AR, Bromberg DJ, Azbel L, Rozanova J, Madden L, Meyer JP, Altice FL. Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information. International Journal Of Drug Policy 2021, 94: 103209. PMID: 33838398, PMCID: PMC8373625, DOI: 10.1016/j.drugpo.2021.103209.Peer-Reviewed Original ResearchConceptsKyrgyz prisonsInformal governance systemSecondary thematic analysisMethadone uptakePrison governanceGovernance systemPrison economyPrison administrationQualitative interviewsInterrelated themesSocial risksPrison contextEastern EuropePrisonCentral AsiaKyrgyz RepublicUnderstanding contextThematic analysisDecisional considerationsContent analysisMethadone treatmentRespondents' perceptionsHIV preventionMethadone utilizationInterviews
2018
Modeling Strengthens Molecular Link between Circadian Polymorphisms and Major Mood Disorders
Liberman AR, Halitjaha L, Ay A, Ingram KK. Modeling Strengthens Molecular Link between Circadian Polymorphisms and Major Mood Disorders. Journal Of Biological Rhythms 2018, 33: 318-336. PMID: 29614896, DOI: 10.1177/0748730418764540.Peer-Reviewed Original ResearchConceptsSingle nucleotide polymorphismsCircadian phenotypesMammalian circadian clockCircadian gene expressionCLOCK polymorphismsClock gene mutationsRecent genetic studiesIntronic single nucleotide polymorphismKnockdown conditionsCircadian clockTranscription rateMolecular linkGene expressionCircadian genesMolecular mechanismsGenetic studiesFunction mutationsNucleotide polymorphismsLength polymorphismClock gene polymorphismsGenotypic associationPolymorphismGene variantsMutationsPhenotype
2017
Circadian Clock Model Supports Molecular Link Between PER3 and Human Anxiety
Liberman AR, Kwon SB, Vu HT, Filipowicz A, Ay A, Ingram KK. Circadian Clock Model Supports Molecular Link Between PER3 and Human Anxiety. Scientific Reports 2017, 7: 9893. PMID: 28860482, PMCID: PMC5579000, DOI: 10.1038/s41598-017-07957-4.Peer-Reviewed Original Research